Humalog kwikpen and Digoxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humalog kwikpen (insulin lispro recombinant) and Digoxin (digoxin). Common drug interactions include anaemia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Humalog kwikpen and Digoxin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Humalog kwikpen?

Humalog kwikpen has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 3,512 Humalog kwikpen users. Check the latest studies of Humalog kwikpen.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

On Jul, 12, 2026

18 people who take Humalog kwikpen and Digoxin together, and have interactions are studied.

Humalog kwikpen and Digoxin drug interactions.

What are the common drug interactions of Humalog Kwikpen and Digoxin, by gender? *:

female:

Anaemia (lack of blood)
Blood glucose increased
Blood pressure increased
Cough
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Influenza
Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nasopharyngitis (inflammation of the nasopharynx)
Oropharyngeal pain

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Cardiac failure congestive
Chest pain
Dizziness
Dyspnoea (difficult or laboured respiration)
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Plasma cell myeloma (cancer that begins in plasma cells)
Pulmonary oedema (fluid accumulation in the lungs)
Staphylococcal infection (an infection with staphylococcus bacteria)

What are the common drug interactions of Humalog Kwikpen and Digoxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Blood glucose increased
Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)

60+:

Ammonia increased
Death
Cardiac failure congestive
Cough
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Influenza
Nasopharyngitis (inflammation of the nasopharynx)
Diarrhoea
Fall
Hip fracture

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 38.89%
Cardiac Disorder: 3 people, 16.67%
Gastric Ulcer (stomach ulcer): 3 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
High Blood Pressure: 3 people, 16.67%
Indigestion: 3 people, 16.67%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 11.11%
Ammonia Increased: 2 people, 11.11%
Nausea (feeling of having an urge to vomit): 2 people, 11.11%
Nausea And Vomiting: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog kwikpen and Digoxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously